why choose us

First received: March 15, 2023

Clinical Trial: A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Mantle Cell Lymphoma

Study Type: INTERVENTIONAL


Official Title: Phase 2 Study of Tafasitamab and Lenalidomide in Relapsed or Refractory Mantle Cell Lymphoma

Brief Summary: The purpose of this study is to determine if the combination of tafasitamab and lenalidomide is an effective treatment for relapsed or refractory Mantle Cell Lymphoma.

Read more